Drug Approval | January 18, 2024
Indoco Remedies receives EIR from USFDA for Goa Plant-I
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The PAI was conducted for two drug product applications (ANDAs) filed from this facility
The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device
Beneficiaries can create Ayushman Card from their mobile phone using Ayushman App which has been downloaded 52 lakh times since its launch on 13th September, 2023
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Signs MoU with the Govt. of Gujarat at Vibrant Gujarat Summit
TALZENNA is the first and only PARP inhibitor approved in combination with standard of care XTANDI for mCRPC patients in the European Union
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Subscribe To Our Newsletter & Stay Updated
